The present study demonstrated, for the first time, that CaSR contributes to cardiac hypertrophy and apoptosis by increasing [Ca2+]i and activating Ca2+-dependent CaMKII and CaN pathways. The gene discussed is CASR; the disease is cardiac hypertrophy.